Mismatch Repair Germline Pathogenic Variants Could Predispose to Uveal Melanoma

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on June 20, 2025.

via HealthDay

FRIDAY, June 20, 2025 -- Mismatch repair (MMR) germline alterations are enriched among patients with uveal melanoma (UM), according to a study published online June 18 in JAMA Ophthalmology.

Anaïs Le Ven, from Inserm U1339 in Paris, and colleagues conducted a prospective cohort study involving 381 consecutive patients diagnosed with UM between July 2021 and February 2023 to identify new genetic alterations predisposing for UM. All participants consented to extended genetic testing; a panel of 122 genes predisposing to cancer were analyzed by targeted sequencing on germline DNA.

The researchers identified 79 pathogenic variants (PVs) in 70 participants. Twenty-one of these were found in clinically relevant genes, with an enrichment in the MMR genes, involved in Lynch syndrome, suggesting that MMR germline PVs could predispose to UM. One tumor from a participant carrying an MLH1 germline PV exhibited a monosomy 3, with loss of the wild-type allele of MLH1, which is located on chromosome 3. Loss of MLH1 expression was seen by immunohistochemistry; whole-genome sequencing of this tumor identified MMR variant signatures SBS6, ID1, and ID2.

"These findings suggest that MMR germline alterations could explain at least a portion of UM genetics, and that UM could be part of the Lynch syndrome spectrum," the authors write.

One author disclosed ties to the pharmaceutical industry; a second author holds related patents.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords